EDINBURGH, Scotland, Dec. 11, 2025 /PRNewswire/ -- Wobble Genomics, a biotechnology ... San Antonio, Texas. The data demonstrates the ability to ...
News
- Wobble Genomics To Present New Data At SABCS Confirming Platform's Ability To ... - Morningstar
- Roche's Oral SERD Cuts Death Risk by 30% in Early-Stage Breast Cancer - BioSpace
Roche presented these findings at the 2025 San Antonio Breast Cancer Symposium (SABCS). ... biotech and science. He can be reached at tristan ...
- Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase ... - StreetInsider
The additional study results were presented in an oral presentation session at the 2025 San Antonio Breast Cancer Symposium (“SABCS”) today, Thursday, ...
- ADC Post-Endocrine Therapy Misses Mark in Advanced Breast Cancer Trial
SAN ANTONIO -- The antibody-drug conjugate (ADC) sacituzumab govitecan ... Biotechnology. Lathrop had no relevant financial disclosures ...
- Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer ...
... San Antonio Breast Cancer Symposium ("SABCS"), in San Antonio, TX being held at the Henry B. Gonzalez Conven.